SMARCA2 antibody [HMV337] HistoMAX^TM

 

Go to Normal Tissue Gallery Go back to product page Go to HistoMAX page

 

Adrenal gland – Adrenocortical adenoma with a moderate SMARCA2 staining of tumor cells

Anal canal – Squamous cell carcinoma with strong SMARCA2 immunostaining of tumor cells

Breast – Invasive breast cancer of no special type (NST) with strong SMARCA2 staining of tumor cells

Breast – Invasive lobular breast cancer with strong SMARCA2 immunostaining of tumor cells

Colon – Colorectal adenocarcinoma with strong SMARCA2 immunostaining of tumor cells

Colon – Neuroendocrine carcinoma with a reduced SMARCA2 expression in tumor cells. Only about 10_ of tumor cells show a weak SMARCA2 positivity while stroma cells display a strong staining

Colon – SMARCA2 negative neuroendocrine carcinoma

Esophagus – Adenocarcinoma with moderate SMARCA2 immunostaining of tumor cells

Esophagus – SMARCA2 deficient neuroendocrine carcinoma

Esophagus – SMARCA2 negative neuroendocrine carcinoma

Esophagus – Squamous cell carcinoma with strong SMARCA2 staining of tumor cells

Kidney – Chromophobe renal cell carcinoma with weak SMARCA2 staining of tumor cells

Kidney – Clear cell renal cell carcinoma with strong SMARCA2 positivity of tumor cells

Kidney – Papillary renal cell carcinoma with moderate to strong SMARCA2 immunostaining of tumor cells

Liver – Cholangiocellular carcinoma with strong SMARCA2 staining of tumor cells

Liver – Hepatocellular carcinoma with a reduced SMARCA2 expression in tumor cells. Only about 50_ of tumor cells show a weak SMARCA2 positivity while stroma cells show a clearly stronger staining

Lung – Adenocarcinoma with a reduced SMARCA2 expression in tumor cells. About 10_ of tumor cells show a weak SMARCA2 positivity while stroma cells show a strong staining

Lung – Adenocarcinoma with a reduced SMARCA2 expression in tumor cells. About 30_ of tumor cells show a weak SMARCA2 positivity while stroma cells show a strong staining

Lung – SMARCA2 deficient adenocarcinoma

Lung – SMARCA2 negative squamous cell carcinoma

Lymph node – SMARCA2 negative diffuse large B-cell lymphoma. Only non-neoplastic cells show SMARCA2 staining

Lymph node – SMARCA2 negative follicular B-cell lymphoma. Only non-neoplastic cells show SMARCA2 staining

Oral cavity – Squamous cell carcinoma with strong SMARCA2 immunostaining of tumor cells

Ovary – Serous high-grade carcinoma with strong SMARCA2 positivity of all tumor cells

Ovary – Clear cell carcinoma carcinoma with only faint SMARCA2 staining of few tumor cells while stroma cells are strongly positive

Ovary – Clear cell carcinoma with strong SMARCA2 staining of tumor cells

Ovary – Malignant mixed Mullerian tumor showing a strong SMARCA2 immunostaining of sarcomatoid tumor cells while staining is largely lacking in epithelial tumor cells

Ovary – Serous high-grade carcinoma with only faint SMARCA2 staining of few tumor cells while stroma cells are strongly positive

Ovary – SMARCA2 deficient serous high-grade carcinoma

Pancreas – Neuroendocrine tumor displaying a strong SMARCA2 staining of all tumor cells

Pancreas – SMARCA2 negative adenocarcinoma of the papilla Vaterii

Pancreas – SMARCA2 negative neuroendocrine tumor

Prostate – Adenocarcinoma (Gleason 3+3=6) with strong SMARCA2 positivity of tumor cells

Prostate – Adenocarcinoma (Gleason 5+5=10) with strong SMARCA2 staining of all cancer cells

Salivary gland – Warthin tumor showing a strong SMARCA2 immunostaining of tumor cells

Skin – Basal cell carcinoma with strong SMARCA2 immunostaining of tumor cells

Skin – Malignant melanoma showing a faint SMARCA2 staining in only about 60_ of tumor cells

Skin – Malignant melanoma with strong SMARCA2 positivity of tumor cells

Skin – SMARCA2 negative malignant melanoma

Soft tissue – Leiomyosarcoma with strong SMARCA2 positivity of tumor cells

Stomach – Gastrointestinal stromal tumor (GIST) with strong SMARCA2 positivity of all tumor cells

Testis – Seminoma with strong SMARCA2 immunostaining of tumor cells

Testis – SMARCA2 deficient embryonal carcinoma

Urinary bladder – Muscle-invasive urothelial carcinoma showing a strong SMARCA2 positivity of tumor cells

| TOP |